Aretex Capital Partners

Aretex Capital Partners is a private equity firm established in 2018, with headquarters in New York and additional offices in London. The firm focuses on mid-market investments primarily in North America and Europe, targeting sectors such as energy, financial services, consumer products, consumer services, and healthcare. Aretex partners with entrepreneurs and management teams that have a proven track record, aiming to create value by facilitating access to international markets and promoting sustainable growth.

David Badham

Director and Partner

Sergio D'Angelo

Director

Andrew Feller

Co-Founder and Managing Partner

3 past transactions

Building Energy

Private Equity Round in 2018
Building Energy is an Italy-based renewable energy producer that operates as a vertically integrated, multi-technology independent power producer. The company generates electricity from various renewable sources, including wind, solar, hydro, and biomass. Building Energy offers electricity through long-term revenue contracts and actively pursues new and innovative power-generation opportunities to expand its production capabilities. This approach aims to ensure sustainable value for customers, shareholders, and the communities it serves.

Surgical Specialties

Private Equity Round in 2018
Surgical Specialties is a global medical device company focused on high performance wound closure products and surgical knives. SSC has a multi-channel sales strategy including its own branded products as well as OEM and private label product lines and has operations in the United States, China, the United Kingdom, Germany and Mexico, as well as additional global sales and administrative offices.

Alerian

Acquisition in 2018
Alerian is an independent provider of Master Limited Partnership (MLP) and energy infrastructure market intelligence. Its benchmarks, including the flagship Alerian MLP Index (AMZ), are widely used by industry executives, investment professionals, research analysts, and national media to analyze relative performance. As of April 28, 2017, over $18 billion is directly tied to the Alerian Index Series through exchange-traded funds and notes, separately managed accounts, and structured products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.